Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study.
Haner DireskeneliÖmer KaradağAskin AtesAbdurrahman TufanNevsun InancSerdar S KocaGozde Y CetinServet AkarMuhammet CinarSedat YilmazNeslihan YilmazEdiz DalkilicCemal BesBaris YilmazerAli SahinDuygu ErsözlüMehmet E TezcanNesrin SenGokhan KeserUmut KalyoncuArmagan BerkanBasak HacibedelKerem HelvaciogluTeoman Y CesurCanberk S BasibuyukSerdar AlkanLevent Mert GunayPublished in: Rheumatology advances in practice (2022)
The oral route was more frequently preferred by patients compared with physicians, although patients' preference rates showed a slight increase towards the end of the treatment, which might be an important factor for RA outcomes. Better control of disease activity and QoL were achieved at 12 months, regardless of RoA.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- ankylosing spondylitis
- rheumatoid arthritis patients
- ejection fraction
- newly diagnosed
- juvenile idiopathic arthritis
- prognostic factors
- clinical trial
- randomized controlled trial
- type diabetes
- cross sectional
- adipose tissue
- study protocol
- insulin resistance
- interstitial lung disease
- combination therapy
- systemic sclerosis
- weight loss
- replacement therapy
- patient reported